News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
42,051 Results
Type
Article (2725)
Company Profile (31)
Press Release (39294)
Multimedia
Podcasts (17)
Webinars (2)
Section
Business (16025)
Career Advice (78)
Deals (2157)
Drug Delivery (12)
Drug Development (4199)
Employer Resources (10)
FDA (455)
Job Trends (795)
News (20400)
Policy (1053)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
Academia (146)
Accelerated approval (1)
ADA (4)
Allergies (8)
Alliances (3487)
ALS (10)
Alzheimer's disease (82)
Antibody-drug conjugate (ADC) (64)
Approvals (476)
Artificial intelligence (65)
ASCO (16)
Autoimmune disease (45)
Automation (6)
Bankruptcy (13)
Belgium (2)
Best Places to Work (477)
BIO (12)
Biologics (4)
BIOSECURE Act (2)
Biosimilars (28)
BioSpace Insights (15)
Biotechnology (17)
Bispecific (4)
Bladder cancer (12)
Brain cancer (9)
Breast cancer (66)
Cancer (519)
Cardiovascular disease (21)
Career advice (68)
Career pathing (1)
CAR-T (58)
CDC (2)
CDMO (15)
Celiac Disease (1)
Cell therapy (125)
Cervical cancer (10)
Clinical research (3723)
Collaboration (291)
Commercialization (4)
Company closure (4)
Compensation (165)
Complete response letters (2)
COVID-19 (187)
CRISPR (17)
CRO (2)
C-suite (221)
Cystic fibrosis (8)
Data (757)
Denatured (6)
Depression (12)
Dermatology (4)
Diabetes (26)
Diagnostics (529)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (65)
Drug pricing (10)
Duchenne muscular dystrophy (67)
Earnings (4849)
Editorial (6)
Employer branding (1)
Employer resources (8)
ESMO (28)
Events (6828)
Executive appointments (175)
Eye disease (2)
FDA (688)
Fragile X (1)
Friedreich's ataxia (9)
Frontotemporal dementia (1)
Funding (260)
Gene editing (48)
Generative AI (3)
Gene therapy (91)
GLP-1 (86)
Government (165)
Guidances (26)
Healthcare (740)
Hematology (11)
HIV (4)
Huntington's disease (7)
IgA nephropathy (18)
Immunology and inflammation (46)
Immuno-oncology (28)
Indications (13)
Infectious disease (212)
Inflammatory bowel disease (16)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (47)
Interviews (7)
IPO (1006)
IRA (7)
Job creations (291)
Job search strategy (62)
JPM (4)
Kidney cancer (15)
Kidney disease (11)
Labor market (16)
Layoffs (59)
Leadership (4)
Legal (213)
Licensing (15)
Liver cancer (9)
Longevity (7)
Lung cancer (50)
Lung diease (3)
Lymphoma (23)
Machine learning (5)
Management (4)
Manufacturing (104)
Marketing (1)
MASH (19)
Medical device (318)
Medtech (325)
Melanoma (11)
Mergers & acquisitions (1294)
Metabolic disorders (112)
Middle East (2)
mRNA (20)
Multiple sclerosis (30)
Multispecific (1)
Netherlands (2)
Neurodegenerative disease (46)
Neuropsychiatric disorders (14)
Neuroscience (240)
NextGen: Class of 2026 (354)
Non-profit (159)
Now hiring (18)
Obesity (56)
Opinion (21)
Ovarian cancer (36)
Pain (46)
Pancreatic cancer (30)
Parkinson's disease (17)
Partnered (4)
Patents (80)
Patient recruitment (66)
Patient selection (13)
Peanut (1)
People (6150)
Pharmaceutical (2)
Phase 1 (1588)
Phase 2 (1828)
Phase 3 (993)
Pipeline (1056)
Policy (19)
Postmarket research (30)
Preclinical (682)
Press Release (3)
Prostate cancer (10)
Psychedelics (7)
Radioligand (1)
Radiopharmaceuticals (26)
Rare diseases (120)
Real estate (425)
Recruiting (5)
Regenerative medicine (1)
Regulatory (1046)
Reports (7)
Research institute (150)
Resumes & cover letters (9)
Rett syndrome (5)
RNA editing (7)
RSV (3)
Saudi Arabia (1)
Schizophrenia (18)
Series A (65)
Series B (31)
Sickle cell disease (4)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (507)
Stomach cancer (4)
Supply chain (6)
Tariffs (2)
The Weekly (11)
Vaccines (79)
Venture capital (25)
Weight loss (32)
Wet AMD (1)
Women's health (32)
Women in leadership (1)
Worklife (2)
Date
Today (2)
Last 7 days (61)
Last 30 days (291)
Last 365 days (2459)
2026 (2259)
2025 (2437)
2024 (2589)
2023 (2855)
2022 (3752)
2021 (4041)
2020 (3463)
2019 (2057)
2018 (1559)
2017 (1797)
2016 (1619)
2015 (1830)
2014 (1367)
2013 (1185)
2012 (1392)
2011 (1328)
2010 (1174)
Location
Africa (43)
Alabama (3)
Arizona (21)
Asia (2059)
Australia (313)
California (2357)
Canada (366)
China (146)
Colorado (86)
Connecticut (27)
Delaware (20)
Europe (4197)
Florida (87)
Georgia (19)
Hawaii (2)
Idaho (3)
Illinois (36)
India (7)
Indiana (81)
Japan (27)
Kansas (17)
Kentucky (1)
Louisiana (2)
Maryland (91)
Massachusetts (876)
Michigan (15)
Minnesota (35)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (4)
New Hampshire (4)
New Jersey (203)
New York (134)
North Carolina (183)
Northern California (1225)
Ohio (69)
Oklahoma (3)
Oregon (7)
Pennsylvania (170)
Puerto Rico (2)
Rhode Island (5)
South America (40)
South Carolina (3)
Southern California (958)
Tennessee (6)
Texas (227)
United States (4770)
Utah (9)
Virginia (18)
Washington D.C. (4)
Washington State (124)
West Virginia (1)
Wisconsin (24)
42,051 Results for "anixa biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anixa Biosciences Announces Issuance of Canadian Patent Strengthening International Protection for its Ovarian Cancer Vaccine Technology
November 19, 2026
·
6 min read
Press Releases
Anixa Biosciences and Curia will Develop Final Formulation for Breast Cancer Vaccine in Preparation for Phase 2 Clinical Trial
November 18, 2026
·
5 min read
Press Releases
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
October 26, 2026
·
5 min read
Press Releases
Anixa Biosciences Announces Presentation of Ovarian Cancer CAR-T Clinical Trial at ESMO Immuno-Oncology & Advanced Therapies Congress 2026
November 4, 2026
·
5 min read
Press Releases
Anixa Biosciences Appoints UPenn’s Dr. Carmen Guerra to Cancer Business Advisory Board
September 16, 2026
·
5 min read
Press Releases
Anixa Biosciences’ Ovarian Cancer CAR-T Therapy Inventor to Deliver Keynote at Ovarian Cancer Midwest Focus Conference
October 13, 2026
·
5 min read
Press Releases
Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial
October 5, 2026
·
5 min read
Press Releases
Anixa Biosciences Granted First Australian Patent for its Breast Cancer Vaccine, Broadening Global Protection Through 2040
September 21, 2026
·
6 min read
Press Releases
Anixa Biosciences Announces Treatment of Second Patient in the Fifth Cohort of its Ovarian Cancer CAR-T Clinical Trial
October 1, 2026
·
5 min read
Press Releases
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
September 3, 2026
·
4 min read
1 of 4,206
Next